# A Long-term Follow-up Study of Patients Who Received MB-105

> **NCT07340814** · — · NOT_YET_RECRUITING · sponsor: **March Biosciences Inc** · enrollment: 40 (estimated)

## Conditions studied

- Any Patient Treated With MB-105

## Interventions

- **BIOLOGICAL:** MB-105

## Key facts

- **NCT ID:** NCT07340814
- **Lead sponsor:** March Biosciences Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-27
- **Primary completion:** 2040-10-15
- **Final completion:** 2040-10-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07340814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07340814, "A Long-term Follow-up Study of Patients Who Received MB-105". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07340814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*